Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 28, 2024 07:45 ET
NeuralAI Launches AI 3D Asset Generator with TAO Bittensor Subnet: Transforming 3D Model Creation for Games and Beyond
NeuralAI is thrilled to announce the launch of its groundbreaking AI-based 3D game asset generator, designed to revolutionize the way 3D models are produced. NeuralAI leverages advanced generative artificial intelligence to enable text-to-3D and...
May 28, 2024 07:37 ET
CAE, INC. ALERT: CAE, Inc. Falls after Announcing Impairment Charges (NYSE: CAE) – Investors are Encouraged to Contact BFA Law About Your Rights
Top securities law firm Bleichmar Fonti & Auld LLP announces an investigation into CAE, Inc. (NYSE: CAE) for potential violations of the federal securities laws. If you invested in CAE, you are encouraged to obtain additional information by...
May 28, 2024 07:35 ET
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis
Numab Therapeutics AG (Numab), a clinical stage biotechnology company advancing a proprietary pipeline of immunology and oncology therapeutics, announced today that the Company has entered into a definitive agreement whereby Johnson & Johnson1...
May 28, 2024 07:34 ET
Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter
Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, today announced its financial results for the three months ended March 31, 2024....
May 28, 2024 07:33 ET
Inter&Co doubles down on SMEs through acquisition of Granito
Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), announces that Banco Inter S.A. entered into a share purchase agreement to acquire the remaining 50 percent of Granito, a merchant acquirer that provides financial services to more than 100,000 SMEs across...
May 28, 2024 07:32 ET
WIDEOPENWEST ALERT: WideOpenWest’s $4.80 Per Share Offer from DigitalBridge is Under Investigation (NYSE: WOW) – Contact BFA Law to Discuss How this Impacts You
Leading law firm Bleichmar Fonti & Auld LLP is investigating the (NYSE: WOW) WideOpenWest merger with DigitalBridge and Crestview. If you invested in WideOpenWest you are encouraged to contact BFA Law by visiting...
May 28, 2024 07:31 ET
SQUARESPACE ALERT: Squarespace’s $44 Per Share Buyout Offer From Permira is Under Investigation (NYSE: SQSP) - Contact BFA Law to Discuss How this Impacts You
Leading law firm Bleichmar Fonti & Auld LLP is investigating the (NYSE: SQSP) Squarespace buyout from Permira. If you invested in Squarespace you are encouraged to obtain additional information by visiting...
May 28, 2024 07:30 ET
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its senior management team will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 11:30 a.m. Eastern Time. The Company...
May 28, 2024 07:30 ET
Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement
Agrify Corporation (Nasdaq:AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that after the recent $13.8 million debt-to-equity conversions by CP...
May 28, 2024 07:30 ET
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease (COPD) and other inflammatory and immunology (I&I)...
May 28, 2024 07:30 ET
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly-owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat...
May 28, 2024 07:30 ET
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the closing of its previously announced...
May 28, 2024 07:30 ET
Judge Consulting Recognized on 2024 CRN Solution Provider 500 List
For the third consecutive year, Judge Consulting, a division of The Judge Group, has been named to the Solution Provider 500 by CRN, a brand of The Channel Company. The annual Solution Provider 500 list recognizes North America's largest solution...
May 28, 2024 07:30 ET
KANZHUN LIMITED repurchased RMB74 million ordinary shares under its repurchase plan
KANZHUN LIMITED (“BOSS Zhipin” or the “Company”), a leading online recruitment platform in China, recently announced that the Company has implemented a repurchase plan and repurchased nearly 1 million ordinary shares with a total value of more than...
May 28, 2024 07:30 ET
Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director Nominees on the BLUE Proxy Card
Medallion Financial Corp. (NASDAQ: MFIN) (“Medallion” or the “Company”) today announced that leading independent proxy advisory firm Institutional Shareholder Services ("ISS") has recommended that Medallion shareholders vote on the BLUE proxy card...
May 28, 2024 07:30 ET
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD),...
May 28, 2024 07:30 ET
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming presentations highlighting study designs for post-marketing studies being undertaken for BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple...
May 28, 2024 07:30 ET
Venus Concept Announces $35 million Debt-to-Equity Exchange Transaction
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that, on May 24, 2024, the Company exchanged $35.0 million of its senior debt held by affiliates of Madryn Asset...
May 28, 2024 07:30 ET
Yorbeau Consolidates Interest in Its Beschefer Property
Yorbeau Resources Inc. (TSX: YRB) (the “Company” or “Yorbeau”) is pleased to announce that it has completed the acquisition of the remaining 20% undivided interest (the “Minority Interest”) in certain mining claims comprising a portion of the...
May 28, 2024 07:26 ET
CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: CERE) – Contact BFA Law to Discuss How this Impacts You
Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between (Nasdaq: CERE) Cerevel Therapeutics Holdings, Inc. and AbbVie, Inc. If you invested in Cerevel Therapeutics you are encouraged to obtain additional information by...